The Twenty-Second Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy, 2007

Molecular Carcinogenesis

Volumn 47, Issue 7, 2008, Pages 554-571

  Sander, Miriam ^a   Slaga, Thomas J ^b   Trump, Benjamin F ^c   Harris, Curtis C ^d,e,f  

^a Page One Editorial Services   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f Bldg 37 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BETA 2 MICROGLOBULIN; BEVACIZUMAB; BIOLOGICAL MARKER; BORTEZOMIB; CETUXIMAB; CISPLATIN; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; GEFITINIB; IMATINIB; LAPATINIB; MICRORNA; NEDD8 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B INHIBITOR; RETINOID; RITUXIMAB; SORAFENIB; TAXANE DERIVATIVE; TRASTUZUMAB; CARCINOGEN;

BONE METASTASIS; BREAST CANCER; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CONFERENCE PAPER; CYTOGENETICS; EPIGENETICS; GENE ACTIVATION; GENE CONTROL; GENE MUTATION; HUMAN; INFLAMMATION; MUTAGENESIS; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOXICITY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; NEOPLASM;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 45949083718     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20408     Document Type: Conference Paper

References (0)